Galmed Pharmaceuticals Ltd.(GLMD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GLMD Galmed Pharmaceuticals Ltd.

未开盘 12-17 16:00:00 EST

0.9153

-0.0645

-6.58%

盘后0.9336

+0.0183+2.00%

19:40 EST

最高1.00	最低0.9110	成交量13.45万
今开0.9700	昨收0.9798	日振幅9.08%
总市值501.51万	流通市值184.44万	总股本547.92万
成交额12.67万	换手率6.67%	流通股本201.51万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GLMD","market":"US","secType":"STK","nameCN":"Galmed Pharmaceuticals Ltd.","latestPrice":0.9153,"timestamp":1766005200000,"preClose":0.9798,"halted":0,"volume":134477,"hourTrading":{"tag":"盘后","latestPrice":0.9336,"preClose":0.9153,"latestTime":"19:40 EST","volume":1309,"amount":1219.2902,"timestamp":1766018423712},"delay":0,"floatShares":2015100,"shares":5479231,"eps":-2.710894,"marketStatus":"未开盘","change":-0.0645,"latestTime":"12-17 16:00:00 EST","open":0.97,"high":1,"low":0.911,"amount":126723.9706236,"amplitude":0.090835,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.710894,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1766048400000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1394683200000,"exchange":"NASDAQ","adjPreClose":0.9798,"preHourTrading":{"tag":"盘前","latestPrice":0.9611,"preClose":0.9798,"latestTime":"08:53 EST","volume":1243,"amount":1185.58824142,"timestamp":1765979596477},"postHourTrading":{"tag":"盘后","latestPrice":0.9336,"preClose":0.9153,"latestTime":"19:40 EST","volume":1309,"amount":1219.2902,"timestamp":1766018423712},"volumeRatio":1.067856,"impliedVol":0.7031,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/GLMD/wiki","defaultTab":"wiki","newsList":[{"id":"1191320516","title":"Galmed公布Aramchol与Madrigal Pharmaceuticals的Rezdiffra（Resmetirom）组合的新用途专利","url":"https://stock-news.laohu8.com/highlight/detail?id=1191320516","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191320516?lang=zh_cn&edition=full","pubTime":"2025-12-04 21:35","pubTimestamp":1764855308,"startTime":"0","endTime":"0","summary":"Galmed公布Aramchol与Madrigal Pharmaceuticals的Rezdiffra（Resmetirom）组合的新用途专利","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLMD","BK4139"],"gpt_icon":0},{"id":"2586706294","title":"Galmed Pharmaceuticals Ltd.盘中异动 快速上涨5.07%报0.864美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586706294","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586706294?lang=zh_cn&edition=full","pubTime":"2025-11-26 23:12","pubTimestamp":1764169926,"startTime":"0","endTime":"0","summary":"北京时间2025年11月26日23时12分，Galmed Pharmaceuticals Ltd.股票出现异动，股价大幅上涨5.07%。截至发稿，该股报0.864美元/股，成交量6.2822万股，换手率1.15%，振幅6.08%。Galmed Pharmaceuticals Ltd.股票所在的生物技术行业中，整体涨幅为0.42%。Galmed Pharmaceuticals Ltd.公司简介：Galmed Pharmaceuticals Ltd 是一家生物制药公司。它侧重于 Aramchol 的发展。该公司目前正在寻求推进 Aramchol 的开发，用于治疗 NASH 和纤维化以外的肿瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126231207a4bc1cbd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126231207a4bc1cbd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLMD"],"gpt_icon":0},{"id":"2585712511","title":"Galmed Pharmaceuticals Ltd.盘中异动 大幅下跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585712511","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585712511?lang=zh_cn&edition=full","pubTime":"2025-11-21 22:32","pubTimestamp":1763735557,"startTime":"0","endTime":"0","summary":"北京时间2025年11月21日22时32分，Galmed Pharmaceuticals Ltd.股票出现异动，股价大幅下跌5.15%。Galmed Pharmaceuticals Ltd.股票所在的生物技术行业中，整体涨幅为0.02%。Galmed Pharmaceuticals Ltd.公司简介：Galmed Pharmaceuticals Ltd 是一家生物制药公司。它侧重于 Aramchol 的发展。该公司目前正在寻求推进 Aramchol 的开发，用于治疗 NASH 和纤维化以外的肿瘤适应症。消息层面，截至22时32分，《Maxim Group维持Galmed Pharmaceuticals持有评级》资讯为影响Galmed Pharmaceuticals Ltd.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511212232379777db8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511212232379777db8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLMD","BK4139"],"gpt_icon":0},{"id":"1168062198","title":"Galmed Pharmaceuticals公布顶线结果：Aramchol Meglumine 400Mg和200Mg颗粒的生物利用度显著提高","url":"https://stock-news.laohu8.com/highlight/detail?id=1168062198","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168062198?lang=zh_cn&edition=full","pubTime":"2025-11-18 21:32","pubTimestamp":1763472741,"startTime":"0","endTime":"0","summary":"Galmed Pharmaceuticals公布顶线结果：Aramchol Meglumine 400Mg和200Mg颗粒的生物利用度显著提高","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GLMD"],"gpt_icon":0},{"id":"1120434294","title":"Galmed发布肿瘤学机制研究的顶线结果：Aramchol、Stivarga®和Metformin三药组合显著增强了胃肠肿瘤细胞的杀伤效果","url":"https://stock-news.laohu8.com/highlight/detail?id=1120434294","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120434294?lang=zh_cn&edition=full","pubTime":"2025-11-17 21:31","pubTimestamp":1763386295,"startTime":"0","endTime":"0","summary":"Galmed发布肿瘤学机制研究的顶线结果：Aramchol、Stivarga®和Metformin三药组合显著增强了胃肠肿瘤细胞的杀伤效果，具备体内和体外的有效性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLMD","BK4139"],"gpt_icon":0},{"id":"2581636988","title":"Galmed Pharmaceuticals Ltd.盘中异动 早盘股价大跌5.09%报1.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581636988","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581636988?lang=zh_cn&edition=full","pubTime":"2025-11-07 22:52","pubTimestamp":1762527161,"startTime":"0","endTime":"0","summary":"北京时间2025年11月07日22时52分，Galmed Pharmaceuticals Ltd.股票出现异动，股价急速跳水5.09%。截至发稿，该股报1.17美元/股，成交量3.4755万股，换手率0.63%，振幅2.11%。Galmed Pharmaceuticals Ltd.股票所在的生物技术行业中，整体跌幅为0.63%。Galmed Pharmaceuticals Ltd.公司简介：Galmed Pharmaceuticals Ltd 是一家生物制药公司。它侧重于 Aramchol 的发展。该公司目前正在寻求推进 Aramchol 的开发，用于治疗 NASH 和纤维化以外的肿瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107225241a4909499&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107225241a4909499&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLMD","BK4139"],"gpt_icon":0},{"id":"2570003590","title":"Galmed Pharmaceuticals Ltd.盘中异动 下午盘股价大跌5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2570003590","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570003590?lang=zh_cn&edition=full","pubTime":"2025-09-26 02:04","pubTimestamp":1758823487,"startTime":"0","endTime":"0","summary":"北京时间2025年09月26日02时04分，Galmed Pharmaceuticals Ltd.股票出现波动，股价大幅下挫5.38%。截至发稿，该股报1.36美元/股，成交量4.6985万股，换手率0.86%，振幅4.86%。Galmed Pharmaceuticals Ltd.股票所在的生物技术行业中，整体跌幅为1.19%。Galmed Pharmaceuticals Ltd.公司简介：Galmed Pharmaceuticals Ltd 是一家生物制药公司。它侧重于 Aramchol 的发展。该公司目前正在寻求推进 Aramchol 的开发，用于治疗 NASH 和纤维化以外的肿瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092602044795452a56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092602044795452a56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLMD"],"gpt_icon":0},{"id":"1190934193","title":"Galmed Pharmaceuticals在英国成立新公司 专注Sedds制剂开发与商业化","url":"https://stock-news.laohu8.com/highlight/detail?id=1190934193","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190934193?lang=zh_cn&edition=full","pubTime":"2025-08-25 19:43","pubTimestamp":1756122197,"startTime":"0","endTime":"0","summary":"Galmed Pharmaceuticals在英国设立了一家新公司，专门负责Sedds制剂的开发和商业化运营。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLMD","BK4139"],"gpt_icon":0},{"id":"1118672018","title":"Galmed Pharmaceuticals：将收购最多25%股本用于Sedds配方的开发与商业化","url":"https://stock-news.laohu8.com/highlight/detail?id=1118672018","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118672018?lang=zh_cn&edition=full","pubTime":"2025-08-25 19:43","pubTimestamp":1756122194,"startTime":"0","endTime":"0","summary":"Galmed Pharmaceuticals宣布，公司将收购最多25%的股本，用于Sedds配方的开发与商业化。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GLMD"],"gpt_icon":0},{"id":"1125453944","title":"Galmed Pharmaceuticals：与Entomus S.r.o.签署终止协议，结束此前公布的约束性条款清单","url":"https://stock-news.laohu8.com/highlight/detail?id=1125453944","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125453944?lang=zh_cn&edition=full","pubTime":"2025-08-25 19:40","pubTimestamp":1756122047,"startTime":"0","endTime":"0","summary":"Galmed Pharmaceuticals宣布，公司已与Entomus S.r.o.达成终止协议，正式结束双方此前公布的具有约束力的条款清单合作安排。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLMD","BK4139"],"gpt_icon":0},{"id":"2558571435","title":"Galmed Pharmaceuticals Ltd.盘中异动 下午盘快速拉升5.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558571435","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558571435?lang=zh_cn&edition=full","pubTime":"2025-08-09 02:59","pubTimestamp":1754679563,"startTime":"0","endTime":"0","summary":"北京时间2025年08月09日02时59分，Galmed Pharmaceuticals Ltd.股票出现波动，股价急速拉升5.84%。Galmed Pharmaceuticals Ltd.股票所在的生物技术行业中，整体跌幅为1.17%。Galmed Pharmaceuticals Ltd.公司简介：Galmed Pharmaceuticals Ltd 是一家生物制药公司。它侧重于 Aramchol 的发展。该公司目前正在寻求推进 Aramchol 的开发，用于治疗 NASH 和纤维化以外的肿瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809025924a47dbd36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809025924a47dbd36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLMD","BK4139"],"gpt_icon":0},{"id":"2557562862","title":"Galmed Pharmaceuticals Ltd.盘中异动 股价大跌5.86%报1.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557562862","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557562862?lang=zh_cn&edition=full","pubTime":"2025-08-07 22:41","pubTimestamp":1754577673,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日22时41分，Galmed Pharmaceuticals Ltd.股票出现异动，股价急速下跌5.86%。截至发稿，该股报1.37美元/股，成交量5.5716万股，换手率1.02%，振幅2.07%。Galmed Pharmaceuticals Ltd.股票所在的生物技术行业中，整体跌幅为0.20%。Galmed Pharmaceuticals Ltd.公司简介：Galmed Pharmaceuticals Ltd 是一家生物制药公司。它侧重于 Aramchol 的发展。该公司目前正在寻求推进 Aramchol 的开发，用于治疗 NASH 和纤维化以外的肿瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080722411394d5bbb9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080722411394d5bbb9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLMD","BK4139"],"gpt_icon":0},{"id":"2557216308","title":"Galmed Pharmaceuticals Ltd.盘中异动 早盘大幅下跌5.00%报1.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557216308","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557216308?lang=zh_cn&edition=full","pubTime":"2025-08-06 22:19","pubTimestamp":1754489975,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日22时19分，Galmed Pharmaceuticals Ltd.股票出现波动，股价急速下跌5.00%。截至发稿，该股报1.52美元/股，成交量6.0332万股，换手率1.10%，振幅2.50%。Galmed Pharmaceuticals Ltd.股票所在的生物技术行业中，整体跌幅为0.20%。Galmed Pharmaceuticals Ltd.公司简介：Galmed Pharmaceuticals Ltd 是一家生物制药公司。它侧重于 Aramchol 的发展。该公司目前正在寻求推进 Aramchol 的开发，用于治疗 NASH 和纤维化以外的肿瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806221935a6d6c873&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806221935a6d6c873&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLMD","BK4139"],"gpt_icon":0},{"id":"2556380207","title":"Galmed Pharmaceuticals Ltd.盘中异动 股价大涨6.45%报1.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556380207","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556380207?lang=zh_cn&edition=full","pubTime":"2025-08-04 22:43","pubTimestamp":1754318581,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日22时43分，Galmed Pharmaceuticals Ltd.股票出现异动，股价急速拉升6.45%。Galmed Pharmaceuticals Ltd.股票所在的生物技术行业中，整体涨幅为0.75%。Galmed Pharmaceuticals Ltd.公司简介：Galmed Pharmaceuticals Ltd 是一家生物制药公司。它侧重于 Aramchol 的发展。该公司目前正在寻求推进 Aramchol 的开发，用于治疗 NASH 和纤维化以外的肿瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080422430194cf0915&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080422430194cf0915&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLMD"],"gpt_icon":0},{"id":"2556819790","title":"Galmed Pharmaceuticals Ltd.盘中异动 早盘股价大跌6.04%报1.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556819790","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556819790?lang=zh_cn&edition=full","pubTime":"2025-08-01 21:38","pubTimestamp":1754055503,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日21时38分，Galmed Pharmaceuticals Ltd.股票出现异动，股价快速跳水6.04%。Galmed Pharmaceuticals Ltd.股票所在的生物技术行业中，整体涨幅为0.75%。其相关个股中，Bioxcel Therapeutics, Inc.、天境生物、4D Molecular Therapeutics, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Salarius Pharmaceuticals, Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为846.60%、116.43%、85.77%，振幅较大的相关个股有Neurosense Therapeutics Ltd.、Bioxcel Therapeutics, Inc.、Tiziana Life Sciences Ltd，振幅分别为27.46%、20.61%、20.40%。Galmed Pharmaceuticals Ltd.公司简介：Galmed Pharmaceuticals Ltd 是一家生物制药公司。该公司目前正在寻求推进 Aramchol 的开发，用于治疗 NASH 和纤维化以外的肿瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801213823972d01fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801213823972d01fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLMD"],"gpt_icon":0},{"id":"2555296310","title":"Galmed Pharmaceuticals Ltd.盘中异动 大幅下跌5.03%报1.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555296310","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555296310?lang=zh_cn&edition=full","pubTime":"2025-07-31 02:55","pubTimestamp":1753901743,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日02时55分，Galmed Pharmaceuticals Ltd.股票出现波动，股价急速下挫5.03%。Galmed Pharmaceuticals Ltd.股票所在的生物技术行业中，整体涨幅为0.50%。Galmed Pharmaceuticals Ltd.公司简介：Galmed Pharmaceuticals Ltd 是一家生物制药公司。它侧重于 Aramchol 的发展。该公司目前正在寻求推进 Aramchol 的开发，用于治疗 NASH 和纤维化以外的肿瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731025544a46c0219&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731025544a46c0219&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLMD"],"gpt_icon":0},{"id":"2555057269","title":"Galmed Pharmaceuticals Ltd.盘中异动 早盘股价大跌5.73%报1.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555057269","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555057269?lang=zh_cn&edition=full","pubTime":"2025-07-29 22:52","pubTimestamp":1753800720,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日22时52分，Galmed Pharmaceuticals Ltd.股票出现波动，股价快速跳水5.73%。Galmed Pharmaceuticals Ltd.股票所在的生物技术行业中，整体涨幅为0.39%。Galmed Pharmaceuticals Ltd.公司简介：Galmed Pharmaceuticals Ltd 是一家生物制药公司。它侧重于 Aramchol 的发展。该公司目前正在寻求推进 Aramchol 的开发，用于治疗 NASH 和纤维化以外的肿瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072922520194c1c636&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072922520194c1c636&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLMD","BK4139"],"gpt_icon":0},{"id":"2552712205","title":"Galmed Pharmaceuticals Ltd.盘中异动 下午盘急速上涨5.47%报2.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552712205","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552712205?lang=zh_cn&edition=full","pubTime":"2025-07-17 01:09","pubTimestamp":1752685793,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日01时09分，Galmed Pharmaceuticals Ltd.股票出现异动，股价大幅拉升5.47%。Galmed Pharmaceuticals Ltd.股票所在的生物技术行业中，整体涨幅为1.24%。Galmed Pharmaceuticals Ltd.公司简介：Galmed Pharmaceuticals Ltd 是一家生物制药公司。它侧重于 Aramchol 的发展。该公司目前正在寻求推进 Aramchol 的开发，用于治疗 NASH 和纤维化以外的肿瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717010954a44f2b68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717010954a44f2b68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLMD","BK4139"],"gpt_icon":0},{"id":"2551187633","title":"Galmed Pharmaceuticals Ltd.盘中异动 急速上涨5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551187633","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551187633?lang=zh_cn&edition=full","pubTime":"2025-07-14 23:08","pubTimestamp":1752505691,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日23时08分，Galmed Pharmaceuticals Ltd.股票出现波动，股价急速拉升5.40%。Galmed Pharmaceuticals Ltd.股票所在的生物技术行业中，整体涨幅为1.26%。Galmed Pharmaceuticals Ltd.公司简介：Galmed Pharmaceuticals Ltd 是一家生物制药公司。它侧重于 Aramchol 的发展。该公司目前正在寻求推进 Aramchol 的开发，用于治疗 NASH 和纤维化以外的肿瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714230812a44a44a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714230812a44a44a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLMD"],"gpt_icon":0},{"id":"2550968601","title":"Galmed Pharmaceuticals Ltd.盘中异动 大幅下跌6.01%报1.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550968601","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550968601?lang=zh_cn&edition=full","pubTime":"2025-07-12 00:47","pubTimestamp":1752252430,"startTime":"0","endTime":"0","summary":"北京时间2025年07月12日00时47分，Galmed Pharmaceuticals Ltd.股票出现异动，股价大幅下跌6.01%。Galmed Pharmaceuticals Ltd.股票所在的生物技术行业中，整体跌幅为0.25%。Galmed Pharmaceuticals Ltd.公司简介：Galmed Pharmaceuticals Ltd 是一家生物制药公司。它侧重于 Aramchol 的发展。该公司目前正在寻求推进 Aramchol 的开发，用于治疗 NASH 和纤维化以外的肿瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712004710953f01ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712004710953f01ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLMD","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.galmedpharma.com","stockEarnings":[{"period":"1week","weight":-0.1365},{"period":"1month","weight":-0.1283},{"period":"3month","weight":-0.3938},{"period":"6month","weight":-0.5105},{"period":"1year","weight":-0.6959},{"period":"ytd","weight":-0.7131}],"compareEarnings":[{"period":"1week","weight":-0.0235},{"period":"1month","weight":0.0086},{"period":"3month","weight":0.0138},{"period":"6month","weight":0.1298},{"period":"1year","weight":0.1111},{"period":"ytd","weight":0.1456}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Galmed Pharmaceuticals Ltd.于2013年7月31日在以色列成立，它是一家以色列的私人公司。公司是一家临床生物制药企业，专注于开发一种新颖、每天一次并且能够口服的用于治疗肝脏疾病及胆固醇结实的药物，并将该药物商业化。","yearOnYearQuotes":[{"month":1,"riseRate":0.545455,"avgChangeRate":0.031845},{"month":2,"riseRate":0.454545,"avgChangeRate":-0.047865},{"month":3,"riseRate":0.272727,"avgChangeRate":-0.072855},{"month":4,"riseRate":0.5,"avgChangeRate":-0.013881},{"month":5,"riseRate":0.416667,"avgChangeRate":-0.089814},{"month":6,"riseRate":0.75,"avgChangeRate":0.160804},{"month":7,"riseRate":0.416667,"avgChangeRate":-0.094546},{"month":8,"riseRate":0.25,"avgChangeRate":-0.058125},{"month":9,"riseRate":0.5,"avgChangeRate":0.034812},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.138105},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.048693},{"month":12,"riseRate":0.416667,"avgChangeRate":0.052233}],"exchange":"NASDAQ","name":"Galmed Pharmaceuticals Ltd.","nameEN":"Galmed Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Galmed Pharmaceuticals Ltd.(GLMD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Galmed Pharmaceuticals Ltd.(GLMD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Galmed Pharmaceuticals Ltd.,GLMD,Galmed Pharmaceuticals Ltd.股票,Galmed Pharmaceuticals Ltd.股票老虎,Galmed Pharmaceuticals Ltd.股票老虎国际,Galmed Pharmaceuticals Ltd.行情,Galmed Pharmaceuticals Ltd.股票行情,Galmed Pharmaceuticals Ltd.股价,Galmed Pharmaceuticals Ltd.股市,Galmed Pharmaceuticals Ltd.股票价格,Galmed Pharmaceuticals Ltd.股票交易,Galmed Pharmaceuticals Ltd.股票购买,Galmed Pharmaceuticals Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Galmed Pharmaceuticals Ltd.(GLMD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Galmed Pharmaceuticals Ltd.(GLMD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}